Ad is loading...

PSTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Poseida Therapeutics (PSTX) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

PSTX is expected to report earnings to fall 257.19% to -33 cents per share on March 06

Poseida Therapeutics PSTX Stock Earnings Reports

Q4'24

Est.

$-0.33

Q3'24

Beat

by $0.63

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.17

Q4'23

Beat

by $0.12

The last earnings report on November 07 showed earnings per share of 20 cents, beating the estimate of -41 cents. With 702.04K shares outstanding, the current market capitalization sits at 269.00M.

View a ticker or compare two or three

Compare

PSTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PSTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

9390 Towne Centre Drive

Phone

+1 858 779-3100

Employees

330

Web

https://www.poseida.com